- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Publication
Slideshow
Dermatology Times
New Drugs Roundup: Dermatology
Author(s):
The July issue of Dermatology Times highlights some newly approved treatments in dermatology including a new wrinkle filler and new treatment for seborrheic keratosis.
The July issue of Dermatology Times highlights some newly approved treatments in dermatology including:Â Eskata for seborrheic keratosis; Actemra (tocilizumab, Genentech) for polyarticular juvenile idiopathic arthritis (PJIA); diacerein 1% ointment for epidemolysis bullosa (EB); Restylane Lift (hyaluronic acid, Galderma) for volumne loss in hands; Cimiza (certolizumab pegol) for moderate-to-severe psoriasis; and, an antimicrobial post-therapy gel (Sonoma) to be used after aesthetic procedures (such laser, microdermabrasion or chemical peels) to sooth itch and other treatment-associated irritations.
